Annette Barnes Selected Research

1-(N-diphenylacetamido)-2-butanol

1/2002

4-(N,N-dipropylamino)benzaldehyde inhibits the oxidation of all-trans retinal to all-trans retinoic acid by ALDH1A1, but not the differentiation of HL-60 promyelocytic leukemia cells exposed to all-trans retinal.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annette Barnes Research Topics

Disease

1	Latent Autoimmune Diabetes in Adults 03/2009
1	Diabetes Mellitus 03/2009
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2007
1	Leukemia 01/2002

Drug/Important Bio-Agent (IBA)

2	Insulin (Novolin)FDA Link 03/2009 - 01/2007
1	CytokinesIBA 03/2009
1	Interleukin-13IBA 01/2007
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2007
1	Interleukin-4 (Interleukin 4)IBA 01/2007
1	Retinaldehyde (Retinal)IBA 01/2002
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2002
1	1-(N-diphenylacetamido)-2-butanolIBA 01/2002
1	4-(N,N-dipropylamino)benzaldehydeIBA 01/2002